BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Coagulation, Inflammatory disorder, Retina, Hematopoietic cell, Bleomycin, rs3825942)
Bookmark Forward

QuickView for MYC (gene)


Body Atlas

Most Correlated Tissues

  1. B lymphocyte (IgM memory) of spleen
  2. Vena cava
  3. Granulocyte-macrophage progenitor cell of bone marrow
  4. B lymphocyte (naive) of spleen
  5. Omental adipose tissue
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Hyperoxia
  2. Whipple's disease
  3. Physical activity
  4. Irritable bowel syndrome
  5. B-cell lymphoma
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. CEP 14083
  2. microcystin RR
  3. FGF10 protein, human
  4. Quinacrine
  5. N-methylpyrrolidone
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. Bcl6
  2. MIR141
  3. KAT5
  4. PRKDC
  5. MAP2K7
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

  1. Cancer Gene Census - mutations in cancer genes
  2. Ovarian HEY cells overexpressing miR-141, miR-200b or miR-205 or with ZEB1 and WNT5A siRNA knockdown
  3. Ovarian cancer HEY cells transfected to express MIRN205 microRNA
  4. Ovarian cystadenocarcinoma HEY cells with overexpression of miR141
  5. Livers of rat exposed to variety of hepatotoxic compounds
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Transcriptional regulation of microsomal prostaglandin E synthase 1 by the proto-oncogene, c-myc, in…
  2. Cooverexpression of EpCAM and c-myc genes in malignant breast tumours.
  3. Expression of C-myc and β-catenin and their correlation in triple negative breast cancer.
  4. Structure-based virtual screening of novel natural alkaloid derivatives as potential binders of h-te…
  5. Generation of precursor, immature, and mature murine B1-cell lines from c-myc/bcl-xL-overexpressing …
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Dose-adjusted EPOCH-R in MYC Positive DLBCL
  2. Phase Ib/2, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Hepatocellular Carcinoma
  3. Phase I, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Solid Tumors, Multiple Myelo…
  4. Study to Evaluate the Efficacy and Safety of CUDC-907 in Patients With RR DLBCL, Including Patients …
  5. BAY 1000394 for MCL-1-, MYC-, and CCNE1-Amplified Tumors
Explore Clinical Trials Results
  • Copyright © 2020 Illumina Inc. All rights reserved.